Portfolio Update

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC All information is at 31 January 2015 and unaudited. Performance at month end with net income reinvested One Three One Since Three Five month months year 1 April years years 2012 Sterling: Share price 4.7% 10.0% 16.3% 52.5% 61.1% 68.6% Net asset value 4.4% 8.8% 15.8% 40.8% 45.0% 64.3% FTSE All-Share Total Return 2.6% 3.9% 7.1% 32.8% 37.1% 61.5% Source: BlackRock BlackRock took over the investment management of the Company with effect from 1 April 2012. At month end Sterling: Net asset value - capital only: 181.46p Net asset value - cum income*: 185.78p Share price: 184.00 Total assets (including income): £51.2m Discount to cum-income NAV: 1.0% Net Gearing: nil Net yield**: 3.0% Ordinary shares in issue***: 26,479,268 Gearing range (as a % of net assets) 0-20% Ongoing charges****: 1.2% * includes net revenue of 4.32 pence per share ** based on an interim dividend of 2.20p per share for the financial year ended 31 October 2014 and a final dividend of 3.50p per share in respect of the year ended 31 October 2013. *** excludes 6,454,664 shares held in treasury **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2014. Benchmark Sector Analysis Total assets (%) Support Services 11.2 Life Insurance 9.9 Tobacco 9.9 Travel & Leisure 9.0 Pharmaceuticals & Biotechnology 8.5 Banks 7.6 Oil & Gas Producers 6.7 Media 5.0 General Retailers 4.1 Mining 3.8 Household Goods & Home Construction 3.4 Non-Life Insurance 3.4 Food Producers 2.8 Electronic & Electrical Equipment 2.6 Financial Services 2.1 Beverages 2.1 Personal Goods 2.1 General Industrials 1.4 Net Current Assets 4.4 Total 100.0 Ten Largest Equity Investments Company Total assets(%) British American Tobacco 5.3 HSBC 4.9 Imperial Tobacco 4.6 AstraZeneca 4.5 Reed Elsevier 3.9 Prudential 3.9 Rio Tinto 3.8 Friends Life 3.5 Wolseley 3.5 Royal Dutch Shell `B' 3.4 Commenting on the markets, Adam Avigdori & Mark Wharrier representing the Investment Manager noted: Markets UK equities rose in January, extending the rebound that began in October. Expectations for positive European Central Bank (ECB) action increased after the Swiss National Bank announced the removal of the cap on the Swiss Franc against the Euro. The ECB announcement of Quantitative Easing (QE) to purchase €60bn per month of eurozone government and asset backed securities had a positive effect on equity markets. Weaker than expected UK fourth quarter GDP led to expectations of UK interest rates being lower for longer. The market was led higher by European focused companies and traditional `bond proxies' such as utilities and companies that have delivered consistent, earnings growth. The search by investors for yield intensified in light of ECB QE further pushing down bond yields. The Company returned 4.4%* in January, outperforming the FTSE All-Share Index total return of 2.6%. Portfolio Performance A broad range of companies contributed positively to performance. Imperial Tobacco, British American Tobacco and Reed Elsevier were all strong performers during the month. Next, announced a rise in expected full year profits following strong sales in the run up to Christmas. Next also benefited from taking a disciplined approach to the "Black Friday" price cutting promotions and announced their fourth special dividend for the year. Our holding in Essentra also benefitted as the shares rebounded on improving sentiment towards the European economy following the ECB's announcement of QE. Essentra currently earns half its revenues from European customers. Our holding in Friends Life continued to rally as the synergies from the combination with Aviva became apparent. One of the biggest detractors to relative performance over the month came from not owning Tesco. The shares, which were one of the weakest performers in 2014, rebounded strongly on hopes that management change can restore value. While the new management team is certainly a step forward, the turnaround is likely to be protracted given the weak balance sheet and the structural changes in the UK supermarket industry, namely the growth of the German discounters and internet shopping. Other detractors over the month were Dixons Carphone, Rio Tinto and Berkeley Group. Activity over the month included new purchases in Lloyds Banking Group and Stagecoach with additions to our holdings in Hays, Imperial Tobacco, Burberry and Next. We reduced our positions in Royal Dutch Shell and British American Tobacco and sold out of Marks & Spencer. Outlook Eurozone economic activity remains subdued despite an increasingly supportive policy response from the ECB, whilst in the US the ending of QE is contributing to uncertainty. We continue to focus more on the specific drivers of individual companies and the ability to determine their future rather than relying on a specific macro outcome. Given the outlook for both economic growth and interest rates remains uncertain, we seek those companies that can drive returns through self-help and have a clear strategy to deploy the cashflow they generate. The portfolio is primarily invested in high free cash flow companies that can sustain cash generation and pay a growing dividend yield, but also has exposure to companies with sustainable growth franchises and turnaround situations. * NAV - Inc. performance. 11 February 2014
UK 100

Latest directors dealings